Medication info
Olmesartan Medoxomil 20 mg Tablets

Olmesartan Medoxomil 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
White Life Sciences Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201403400 · Approved 2014.07.25 · Insurance code 625200680

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further reduction in blood pressure is needed, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect occurs within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy and safety of this drug were observed between older and younger patients; however, the possibility of a more sensitive response in some older patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Child dose
<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
White Life Sciences Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is treated to lower blood pressure reliably, which reduces the strain on the heart and blood vessels and decreases the risk of complications such as stroke or myocardial infarction. This medication controls blood pressure and improves the overall health of the patient.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further reduction in blood pressure is needed, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect occurs within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy and safety of this drug were observed between older and younger patients; however, the possibility of a more sensitive response in some older patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.

Child dose

<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any components of this medication, pregnant women, breastfeeding mothers, patients undergoing kidney dialysis, those with severe liver impairment, and patients with obstructive biliary disease should not take this medication. Additionally, patients with lactose intolerance or certain genetic metabolic disorders should not use this medication. Patients with decreased blood volume or low salt levels may experience a sudden drop in blood pressure early in treatment, so careful monitoring is required. Patients with impaired kidney function or kidney transplant recipients should have their kidney function and electrolyte status monitored regularly through blood tests, and it is not recommended for patients with severe kidney impairment. Dizziness may occur due to blood pressure reduction, so caution is needed while performing dangerous activities like working at heights or driving. This medication is used for the treatment of hypertension and is generally safe, but some patients may experience side effects such as dizziness, headache, abdominal pain, muscle pain, and rash. If taken by a pregnant woman, it may cause serious issues such as reduced kidney function in the fetus, reduced skull development, and amniotic fluid deficiency, so it should be avoided during pregnancy. Breastfeeding mothers should consider discontinuing breastfeeding or stopping the medication, as it may be passed into breast milk. Safety in children has not been established, so caution is needed for use in pediatric patients. Elderly patients may require dosage adjustments or monitoring due to slowed drug metabolism. When co-administering with other medications, blood pressure-lowering effects may increase or blood potassium levels may rise, so consultation with a physician is necessary. In case of overdose, hypotension and arrhythmias may occur, necessitating appropriate emergency treatment if needed. This medication has been reported to have a low risk of carcinogenicity or genotoxicity even with long-term use.

Side effects

  • Dizziness
  • back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • mesenteric vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • increased serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • elevated blood pressure
  • epistaxis
  • asthma
  • postural dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. The appropriate storage temperature is in a cool place between 1 to 25 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.